These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2953077)

  • 21. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
    Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
    Melbye M; Froebel KS; Madhok R; Biggar RJ; Sarin PS; Stenbjerg S; Lowe GD; Forbes CD; Goedert JJ; Gallo RC
    Lancet; 1984 Dec; 2(8417-8418):1444-6. PubMed ID: 6151053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS and haemophilia.
    Bloom AL
    Biomed Pharmacother; 1985; 39(7):355-65. PubMed ID: 3938297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilia care in Zimbabwe.
    Adewuyi JO; Coutts AM; Levy L; Lloyd SE
    Cent Afr J Med; 1996 May; 42(5):153-6. PubMed ID: 8771937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte subset ratios and factor VIII usage in haemophilia.
    Beddall AC; Al-Rubei K; Williams MD; Hill FG
    Arch Dis Child; 1985 Jun; 60(6):530-6. PubMed ID: 3925894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
    Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
    Goldsmith JM; Deutsche J; Tang M; Green D
    Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of HIV infectivity and composition of factor VIII concentrates on the immunity of haemophiliacs positive for HIV antibodies.
    Allain JP; Frommel D; Bosser C; Gazengel C; Larrieu MJ; Sultan Y
    Vox Sang; 1987; 53(1):37-43. PubMed ID: 3116770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
    Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
    Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis.
    Lederman MM
    Thromb Haemost; 2010 Nov; 104(5):911-4. PubMed ID: 20694275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acquired immune deficiency syndrome in hemophiliac subjects].
    Ogata K; Sugihara T; Kamiya T; Saito H
    Rinsho Byori; 1987 Feb; 35(2):141-6. PubMed ID: 3647140
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
    Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
    Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochemical profile of lymphocytes in haemophilia patients at risk of AIDS.
    Gamba G; Ippoliti G; Invernizzi R; Gatti V; Zocchi MT; Perugini O
    Haematologia (Budap); 1989; 22(2):101-8. PubMed ID: 2744636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological investigation in hemophiliacs with and without human immunodeficiency virus (HIV) infection].
    Pang XG; Tang DJ
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):685-7, 729-30. PubMed ID: 1840032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in T-lymphocyte subsets among Danish haemophiliacs: relation to source of factor VIII preparations and high dose factor VIII treatment.
    Gerstoft J; Bentsen K; Scheibel E; Dalsgård-Nielsen J; Gormsen J; Dickmeiss E
    Scand J Haematol; 1984 May; 32(5):544-51. PubMed ID: 6328639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus (HIV) antibodies in patients with haemophilia and other inheritable blood clotting disorders in south west Poland (Lower Silesia region).
    Czerchawski L; Lindhardt BO; Ulrich K; Szymaniec S; Pejcz J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):61-9. PubMed ID: 3148300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA typing in heavily transfused haemophiliacs with or without antibodies against human immunodeficiency virus (HIV).
    Cornu F; Raffoux C; Maisonneuve P; Bardin JM; Sultan Y; Colombani J
    Tissue Antigens; 1987 Feb; 29(2):123-6. PubMed ID: 3474808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.